CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Fresenius Kabi USA LLC v. Watson Laboratories Inc.

1:14-cv-00161

Overview

Case Number 1:14-cv-00161
Filing Date 2014-02-06
Status Terminated
Termination Date 2015-03-18
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Actavis Inc. Operating Company

Represented By

1 Attorneys Listed

Benjamin J. Schladweiler

Greenberg Traurig, LLP

Tel: +1 (302) 661-7394

The Nemours Building, 1007 North Orange Street, Suite 1200

Watson Laboratories Inc. Operating Company

Represented By

3 Attorneys Listed

Benjamin J. Schladweiler

Greenberg Traurig, LLP

Tel: +1 (302) 661-7394

The Nemours Building, 1007 North Orange Street, Suite 1200

Steven A. Maddox

Email: Steven.Maddox@procopio.com

Jeremy J. Edwards

Email: Jeremy.Edwards@procopio.com

Plaintiff

Fresenius Kabi USA LLC Operating Company

Represented By

7 Attorneys Listed

Srikanth K. Reddy

Email: sreddy@goodwinlaw.com

Samuel Sherry

Law Office of Michael R. Abram

115 South Bedford Street, Georgetown, DE 19947

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Laurie S. Gill

Email: lgill@goodwinprocter.com

John T. Bennett

Law Office of Michael R. Abram

115 South Bedford Street, Georgetown, DE 19947

Jennifer L. Ford

Email: jford@goodwinprocter.com

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 8 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials 2 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (8): πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (2 found):
PTAB: 2
USPTO PTAB Trial 2015-11-25
IPR2016-00254

Bass, J Kyle et al. v. Fresenius Kabi USA, LLC

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2015-02-06
IPR2015-00715

Dr. Reddy's Laboratories, Inc. et al. v. Fresenius Kabi USA, LLC

Asserted Patent
Status: Institution Denied
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8476010
Propofol formulations with non-reactive container closures
Filed: 2003-07-10
Issued: 2013-07-02
Expired (Term Ended) +558d PTA
Expires: 2025-01-18

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+558 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

0

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Claim Construction / Markman Filing 2 Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
Joint Claim Construction Chart, by Fresenius Kabi USA LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit ...
Entry #38 • 2014-12-19 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to serve their disclosures pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Elec...
Entry #22 • 2014-06-23 Document →
Procedural / Extension Motion Pending
SO ORDERED, re (22 in 1:14-cv-00161-RGA, 23 in 1:14-cv-00160-RGA) STIPULATION TO EXTEND TIME for the parties to serve their disclosures pursuant to Paragraph 3 ...
Entry #β€” • 2014-06-23
Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 8/15/2014. Amended Pleadings due by 8/15/201...
Entry #15 • 2014-06-03 Document →

Docket Entries

(67 total)
Pleading / Complaint

COMPLAINT filed against Actavis Inc., Watson Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1456779.) - filed by Fresenius Kabi USA LLC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(els) (Entered: 02/07/2014)

Entry #1 • 2014-02-06
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (els) (Entered: 02/07/2014)

Entry #2 • 2014-02-06
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/22/13. Date of Expiration of Patent: 12/1/24.Thirty Month Stay Deadline: N/A(els) (Entered: 02/07/2014)

Entry #3 • 2014-02-06
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,476,010 B2;. (els) (Entered: 02/07/2014)

Entry #4 • 2014-02-06
1

Summons Issued with Magistrate Consent Notice attached as to Actavis Inc. on 2/7/2014; Watson Laboratories Inc. on 2/7/2014. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (els)

Entry #5 • 2014-02-07
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc